{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T05:47:05Z","timestamp":1794116825956,"version":"4.8.0"},"reference-count":158,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>Cardiac allograft vasculopathy (CAV) is a leading contributor to late allograft failure, mortality, and morbidity after heart transplantation. The prevalence of moderate to severe CAV over time has not changed significantly, and CAV remains an important contemporary consideration in post\u2013heart transplantation management. The diagnosis and surveillance of CAV include both established and emerging invasive and noninvasive modalities, with a growing interest in understanding microvascular function and coronary physiology. The management of CAV is primarily focused on the prevention of CAV progression and optimizing traditional cardiovascular risk factors. Although mammalian target of rapamycin inhibitors and statins are central to the prevention of CAV progression, there is a lack of novel therapeutics for CAV. The development of new therapies for CAV will require a better understanding of the immune mechanisms underlying the initiation and perpetuation of this condition. CAV is mediated through a complex process involving cells and soluble factors of both innate and adaptive immune systems. Animal studies demonstrated that T cells play a central role in CAV. Both alloreactive T cells, which recognize donor major histocompatibility complex peptides (indirect allorecognition), and autoreactive T cells directed against heart tissue-specific antigens such as cardiac myosin have been shown to trigger CAV in mice. These processes involve the production of donor-specific antibodies and autoantibodies, respectively. Other studies suggest that CAV could be mediated by bystander T cells in a T cell receptor-independent manner and that CAV requires cooperation between T cells and natural killer cells. In addition, the essential role of interferon-\u03b3 in CAV has been documented. Whether any of these mechanisms pertain to CAV observed in transplanted patients has not been thoroughly investigated. Gaining insights into this question will be instrumental to the design of immune-based therapies for CAV.<\/jats:p>","DOI":"10.1097\/tp.0000000000005453","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T04:00:42Z","timestamp":1752465642000},"page":"e28-e41","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Chronic Rejection Series: Heart Cardiac Allograft Vasculopathy"],"prefix":"10.1097","volume":"110","author":[{"given":"Michael","family":"Rheaume","sequence":"first","affiliation":[{"name":"Peter Munk Cardiac Centre, Toronto General Hospital, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Aleksova","sequence":"additional","affiliation":[{"name":"Peter Munk Cardiac Centre, Toronto General Hospital, Toronto, ON, Canada."},{"name":"Women\u2019s College Research Institute, Women\u2019s College Hospital, Toronto, ON, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joren C.","family":"Madsen","sequence":"additional","affiliation":[{"name":"Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital and Harvard Medical School, Boston, MA."},{"name":"Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Benichou","sequence":"additional","affiliation":[{"name":"Department of Surgery, Center for Transplantation Sciences, Massachusetts General Hospital and Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"key":"R1-20260119","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.healun.2017.07.019","article-title":"The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult heart transplantation report\u20142017; focus theme: allograft ischemic time.","volume":"36","author":"Lund","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R2-20260119","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.healun.2015.08.003","article-title":"The Registry of the International Society for Heart and Lung Transplantation: thirty-second official adult heart transplantation report\u20142015; focus theme: early graft failure.","volume":"34","author":"Lund","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"R3-20260119","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jchf.2017.09.014","article-title":"Changes in outcomes of cardiac allograft vasculopathy over 30 years following heart transplantation.","volume":"5","author":"Tremblay-Gravel","year":"2017","journal-title":"JACC Heart Fail"},{"key":"R4-20260119","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacc.2016.04.033","article-title":"Allograft vasculopathy.","volume":"68","author":"Chih","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R5-20260119","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy\u20142010.","volume":"29","author":"Mehra","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R6-20260119","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.healun.2022.10.015","article-title":"The International Society for Heart and Lung Transplantation (ISHLT) guidelines for the care of heart transplant recipients.","volume":"42","author":"Velleca","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R7-20260119","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jacc.2005.02.035","article-title":"Multicenter intravascular ultrasound validation study among heart transplant recipients.","volume":"45","author":"Kobashigawa","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R8-20260119","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1093\/eurheartj\/ehad648","article-title":"Prognostic value of intravascular ultrasound early after heart transplantation.","volume":"44","author":"Arora","year":"2023","journal-title":"Eur Heart J"},{"key":"R9-20260119","first-page":"e011306","article-title":"Enhancing the prediction of cardiac allograft vasculopathy using intravascular ultrasound and machine learning: a proof of concept.","volume":"17","author":"Moayedi","year":"2024","journal-title":"Circulation"},{"key":"R10-20260119","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.healun.2023.07.006","article-title":"Early optical coherence tomography evaluation of donor-transmitted atherosclerosis and cardiac allograft vasculopathy: insights from a prospective, single-center study.","volume":"42","author":"Takahashi","year":"2023","journal-title":"J Heart Lung Transplant"},{"key":"R11-20260119","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1016\/j.healun.2024.02.407","article-title":"Intravascular imaging volumetric analysis of early cardiac allograft vasculopathy: head-to-head comparison of serial paired intravascular ultrasound and optical coherence tomography.","volume":"43","author":"Bajaj","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"R12-20260119","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/01.CIR.0000091116.84926.6F","article-title":"Simultaneous assessment of fractional and coronary flow reserves in cardiac transplant recipients: physiologic investigation for transplant arteriopathy (PITA Study).","volume":"108","author":"Fearon","year":"2003","journal-title":"Circulation"},{"key":"R13-20260119","article-title":"Fibrotic plaque and microvascular dysfunction predict early cardiac allograft vasculopathy progression after heart transplantation: the early post transplant cardiac allograft vasculopathy study.","volume":"16","author":"Chih","year":"2023","journal-title":"Circulation"},{"key":"R14-20260119","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/echo.14268","article-title":"Diagnostic accuracy of dobutamine stress echocardiography in the detection of cardiac allograft vasculopathy in heart transplant recipients: a systematic review and meta\u2010analysis study.","volume":"36","author":"Elkaryoni","year":"2019","journal-title":"Echocardiogr"},{"key":"R15-20260119","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s12350-020-02342-7","article-title":"Prognostic utility of longitudinal quantification of PET myocardial blood flow early post heart transplantation.","volume":"29","author":"Wiefels","year":"2022","journal-title":"J Nuclear Cardiol"},{"key":"R16-20260119","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jchf.2022.11.012","article-title":"Negative predictive value and prognostic associations of Rb-82 PET\/CT with myocardial blood flow in CAV.","volume":"11","author":"Abadie","year":"2023","journal-title":"JACC Heart Fail"},{"key":"R17-20260119","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/eurheartj\/ehx683","article-title":"Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy.","volume":"39","author":"Bravo","year":"2018","journal-title":"Eur Heart J"},{"key":"R18-20260119","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jacc.2022.08.751","article-title":"Noninvasive physiologic assessment of cardiac allograft vasculopathy is prognostic for post-transplant events.","volume":"80","author":"Clerkin","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R19-20260119","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.jcmg.2023.10.003","article-title":"Cardiac PET myocardial blood flow quantification assessment of early cardiac allograft vasculopathy.","volume":"17","author":"Chih","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"R20-20260119","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1016\/j.jacc.2014.01.071","article-title":"Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy.","volume":"63","author":"Wever-Pinzon","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R21-20260119","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jcmg.2022.12.031","article-title":"CT coronary angiography and dynamic CT myocardial perfusion for detection of cardiac allograft vasculopathy.","volume":"16","author":"Ahn","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"R22-20260119","first-page":"e009060","article-title":"Myocardial fibrosis and prognosis in heart transplant recipients.","volume":"12","author":"Hughes","year":"2019","journal-title":"Circulation"},{"key":"R23-20260119","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/ehjci\/jew186","article-title":"Prognostic impact of late gadolinium enhancement in the risk stratification of heart transplant patients.","volume":"18","author":"Pedrotti","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"R24-20260119","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cardfail.2022.10.076","article-title":"Structural parameters by cardiac magnetic resonance imaging to detect cardiac allograft vasculopathy beyond the first-year post-heart transplantation: a prospective single center analysis.","volume":"29","author":"Abbasi","year":"2023","journal-title":"J Card Fail"},{"key":"R25-20260119","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/j.1600-6143.2010.03118.x","article-title":"Systemic markers of inflammation are associated with cardiac allograft vasculopathy and an increased intimal inflammatory component.","volume":"10","author":"Arora","year":"2010","journal-title":"Am J Transplant"},{"key":"R26-20260119","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1159\/000509630","article-title":"Prognostic value of biomarkers in cardiac allograft vasculopathy following heart transplantation: a literature review.","volume":"145","author":"Habibi","year":"2020","journal-title":"Cardiology"},{"key":"R27-20260119","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/01.tp.0000263338.39555.21","article-title":"Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.","volume":"83","author":"Arora","year":"2007","journal-title":"Transplantation"},{"key":"R28-20260119","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0735-1097(22)01475-9","article-title":"High sensitivity troponin 1 as a novel biomarker for cardiac allograft vasculopathy.","volume":"79","author":"Patel","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R29-20260119","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.amjcard.2004.04.060","article-title":"Usefulness of an elevated B-type natriuretic peptide to predict allograft failure, cardiac allograft vasculopathy, and survival after heart transplantation.","volume":"94","author":"Mehra","year":"2004","journal-title":"Am J Cardiol"},{"key":"R30-20260119","doi-asserted-by":"crossref","first-page":"102011","DOI":"10.1016\/j.trim.2024.102011","article-title":"Role of HLA matching and donor specific antibody development in long-term survival, acute rejection and cardiac allograft vasculopathy.","volume":"83","author":"Costa","year":"2024","journal-title":"Transpl Immunol"},{"key":"R31-20260119","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1111\/ajt.15339","article-title":"Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: a prospective multicenter study.","volume":"19","author":"Khush","year":"2019","journal-title":"Am J Transplant"},{"key":"R32-20260119","doi-asserted-by":"crossref","first-page":"e14206","DOI":"10.1111\/ctr.14206","article-title":"Donor\u2010derived cell\u2010free DNA is associated with cardiac allograft vasculopathy.","volume":"35","author":"Holzhauser","year":"2021","journal-title":"Clin Transplant"},{"key":"R33-20260119","doi-asserted-by":"crossref","first-page":"856600","DOI":"10.3389\/fcvm.2022.856600","article-title":"Lack of usefulness of donor-derived cell-free DNA as a biomarker for cardiac allograft vasculopathy: a prospective study.","volume":"9","author":"Jim\u00e9nez-Blanco Bravo","year":"2022","journal-title":"Front Cardiovas Med"},{"key":"R34-20260119","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jchf.2022.11.002","article-title":"The end of endomyocardial biopsy?","volume":"11","author":"Holzhauser","year":"2023","journal-title":"JACC Heart Fail"},{"key":"R35-20260119","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamacardio.2018.3965","article-title":"Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure.","volume":"4","author":"Dorsheimer","year":"2019","journal-title":"JAMA Cardiol"},{"key":"R36-20260119","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2021.02.028","article-title":"Clonal hematopoiesis and risk of progression of heart failure with reduced left ventricular ejection fraction.","volume":"77","author":"Pascual-Figal","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R37-20260119","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1111\/ajt.17172","article-title":"Clonal hematopoiesis confers an increased mortality risk in orthotopic heart transplant recipients.","volume":"22","author":"Scolari","year":"2022","journal-title":"Am J Transplant"},{"key":"R38-20260119","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ajt.2023.02.025","article-title":"The evolving use of biomarkers in heart transplantation: consensus of an expert panel.","volume":"23","author":"Kobashigawa","year":"2023","journal-title":"Am J Transplant"},{"key":"R39-20260119","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1097\/TP.0000000000001477","article-title":"MicroRNA 628-5p as a novel biomarker for cardiac allograft vasculopathy.","volume":"101","author":"Neumann","year":"2017","journal-title":"Transplantation"},{"key":"R40-20260119","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation.","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"N Engl J Med"},{"key":"R41-20260119","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.healun.2005.02.009","article-title":"Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients.","volume":"24","author":"Kobashigawa","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R42-20260119","doi-asserted-by":"crossref","first-page":"e003265","DOI":"10.1161\/CIRCHEARTFAILURE.116.003265","article-title":"Impact of statin use after heart transplantation: a meta-analysis.","volume":"9","author":"Vallakati","year":"2016","journal-title":"Circ Heart Fail"},{"key":"R43-20260119","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.jchf.2024.04.026","article-title":"Randomized trial of cholesterol lowering with evolocumab for cardiac allograft vasculopathy in heart transplant recipients.","volume":"12","author":"Broch","year":"2024","journal-title":"JACC Heart Fail"},{"key":"R44-20260119","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10741-022-10255-5","article-title":"PCSK9 inhibitors safely and effectively lower LDL after heart transplantation: a systematic review and meta-analysis.","volume":"28","author":"Jennings","year":"2023","journal-title":"Heart Fail Rev"},{"key":"R45-20260119","doi-asserted-by":"crossref","first-page":"e14424","DOI":"10.1111\/ctr.14424","article-title":"Early aspirin use, allograft rejection, and cardiac allograft vasculopathy in heart transplantation.","volume":"35","author":"Bergmark","year":"2021","journal-title":"Clin Transplant"},{"key":"R46-20260119","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.1016\/j.healun.2019.01.706","article-title":"Does aspirin reduce the rate of early cardiac allograft vasculopathy (CAV) following heart transplant?","volume":"38","author":"Bloom","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R47-20260119","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.cardfail.2015.06.326","article-title":"The role of aspirin in the prevention of coronary allograft vasculopathy in cardiac transplant patients.","volume":"21","author":"Benes","year":"2015","journal-title":"J Card Fail"},{"key":"R48-20260119","doi-asserted-by":"crossref","first-page":"e13133","DOI":"10.1111\/ctr.13133","article-title":"Early aspirin initiation following heart transplantation is associated with reduced risk of allograft vasculopathy during long\u2010term follow\u2010up.","volume":"31","author":"Peled","year":"2017","journal-title":"Clin Transplant"},{"key":"R49-20260119","first-page":"449","article-title":"Low-dose aspirin and accelerated coronary disease in heart transplant recipients.","volume":"9","author":"de Lorgeril","year":"1990","journal-title":"J Heart Transplant"},{"key":"R50-20260119","doi-asserted-by":"crossref","first-page":"e14125","DOI":"10.1111\/ctr.14125","article-title":"The effect of antiplatelet therapy on survival and cardiac allograft vasculopathy following heart transplantation: a systematic review and meta\u2010analysis.","volume":"35","author":"Aleksova","year":"2021","journal-title":"Clin Transplant"},{"key":"R51-20260119","first-page":"1337","article-title":"The Canadian Study of Cardiac Transplantation. Atherosclerosis. Investigators of the CASCADE Study.","volume":"15","author":"Carrier","year":"1999","journal-title":"Can J Cardiol"},{"key":"R52-20260119","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.healun.2004.06.005","article-title":"The effect of combined angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound.","volume":"24","author":"Erinc","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R53-20260119","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/CIRCULATIONAHA.107.692996","article-title":"Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.","volume":"116","author":"Raichlin","year":"2007","journal-title":"Circulation"},{"key":"R54-20260119","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/CIRCULATIONAHA.111.040360","article-title":"Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation.","volume":"125","author":"Topilsky","year":"2012","journal-title":"Circulation"},{"key":"R55-20260119","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijcard.2018.03.111","article-title":"Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: a meta-analysis.","volume":"265","author":"Jennings","year":"2018","journal-title":"Int J Cardiol"},{"key":"R56-20260119","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/ajt.12208","article-title":"Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice.","volume":"13","author":"Masetti","year":"2013","journal-title":"Am J Transplant"},{"key":"R57-20260119","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2017.12.005","article-title":"Long-term sirolimus for primary immunosuppression in heart transplant recipients.","volume":"71","author":"Asleh","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R58-20260119","doi-asserted-by":"crossref","first-page":"e004050","DOI":"10.1161\/CIRCHEARTFAILURE.117.004050","article-title":"Effect of everolimus initiation and calcineurin inhibitor elimination on cardiac allograft vasculopathy in de novo heart transplant recipients.","volume":"11","author":"Arora","year":"2018","journal-title":"Circ Heart Fail"},{"key":"R59-20260119","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/TP.0b013e31822057f1","article-title":"Effect of everolimus introduction on cardiac allograft vasculopathy\u2014results of a randomized, multicenter trial.","volume":"92","author":"Arora","year":"2011","journal-title":"Transplantation"},{"key":"R60-20260119","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.healun.2004.10.005","article-title":"Long-term results of angioplasty vs stenting in cardiac transplant recipients with allograft vasculopathy.","volume":"24","author":"Simpson","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R61-20260119","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/j.jacc.2004.02.045","article-title":"Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experience.","volume":"43","author":"Benza","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R62-20260119","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.amjcard.2018.01.025","article-title":"Role of percutaneous coronary intervention in the treatment of cardiac allograft vasculopathy.","volume":"121","author":"Lee","year":"2018","journal-title":"Am J Cardiol"},{"key":"R63-20260119","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00392-023-02351-9","article-title":"Safety and efficacy of everolimus-eluting bioresorbable vascular scaffold for cardiac allograft vasculopathy (CART).","volume":"113","author":"Pighi","year":"2024","journal-title":"Clin Res Cardiol"},{"key":"R64-20260119","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000524781","article-title":"Coronary artery revascularization in heart transplant patients: a systematic review and meta-analysis.","volume":"147","author":"El-Andari","year":"2022","journal-title":"Cardiology"},{"key":"R65-20260119","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/ajt.13418","article-title":"Retransplant and medical therapy for cardiac allograft vasculopathy: International Society for Heart and Lung Transplantation registry analysis.","volume":"16","author":"Goldraich","year":"2016","journal-title":"Am J Transplant"},{"key":"R66-20260119","doi-asserted-by":"crossref","first-page":"1444924","DOI":"10.3389\/fimmu.2024.1444924","article-title":"The potential of autologous regulatory T cell (Treg) therapy to prevent cardiac allograft vasculopathy (CAV) in paediatric heart transplant recipients.","volume":"15","author":"Aiyengar","year":"2024","journal-title":"Front Immunol"},{"key":"R67-20260119","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/ajt.17206","article-title":"Targeting IL-6 to prevent cardiac allograft rejection.","volume":"22","author":"Miller","year":"2022","journal-title":"Am J Transplant"},{"key":"R68-20260119","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.healun.2023.02.522","article-title":"(507) Leukotriene B4 mediates development of cardiac allograft vasculopathy after heart transplantation.","volume":"42","author":"Khush","year":"2023","journal-title":"J Heart Lung Transplant"},{"issue":"Supplement_1","key":"R69-20260119","doi-asserted-by":"crossref","first-page":"bvad114.733","DOI":"10.1210\/jendso\/bvad114.733","article-title":"THU298 effect of SGLT2 inhibition on metabolic, cardiac and renal outcomes in heart transplant recipients (EMPA-HTx study): protocol and study design.","volume":"7","author":"Raven","year":"2023","journal-title":"J Endocr Soc"},{"key":"R70-20260119","doi-asserted-by":"crossref","first-page":"e15401","DOI":"10.1111\/ctr.15401","article-title":"Cardio\u2010renal\u2010metabolic outcomes associated with the use of GLP\u20101 receptor agonists after heart transplantation.","volume":"38","author":"Donald","year":"2024","journal-title":"Clin Transplant"},{"key":"R71-20260119","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.healun.2005.06.008","article-title":"Of mice and men: mouse models and the molecular mechanisms of post-transplant coronary artery disease.","volume":"24","author":"George","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"R72-20260119","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1172\/JCI10467","article-title":"CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II.","volume":"106","author":"Pietra","year":"2000","journal-title":"J Clin Invest"},{"key":"R73-20260119","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/TP.0b013e3181b076cc","article-title":"Contribution of B cells and antibody to cardiac allograft vasculopathy.","volume":"88","author":"Gareau","year":"2009","journal-title":"Transplantation"},{"key":"R74-20260119","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/01.RES.0000261982.76892.09","article-title":"Vascular remodeling in transplant vasculopathy.","volume":"100","author":"Mitchell","year":"2007","journal-title":"Circ Res"},{"key":"R75-20260119","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(01)00119-4","article-title":"Chronic rejection.","volume":"14","author":"Libby","year":"2001","journal-title":"Immunity"},{"key":"R76-20260119","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.trim.2004.12.003","article-title":"Impairment of recipient cytolytic activity attenuates allograft vasculopathy.","volume":"14","author":"Skaro","year":"2005","journal-title":"Transpl Immunol"},{"key":"R77-20260119","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cardiores.2004.09.023","article-title":"CD8+ T cells mediate aortic allograft vasculopathy by direct killing and an interferon-gamma-dependent indirect pathway.","volume":"65","author":"Skaro","year":"2005","journal-title":"Cardiovasc Res"},{"key":"R78-20260119","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.trim.2005.02.006","article-title":"Aortic allograft vasculopathy is mediated by CD8(+) T cells in cyclosporin A immunosuppressed mice.","volume":"15","author":"Vessie","year":"2005","journal-title":"Transpl Immunol"},{"key":"R79-20260119","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1073\/pnas.93.9.4051","article-title":"Immunologic basis of transplant-associated arteriosclerosis.","volume":"93","author":"Shi","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R80-20260119","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1053-2498(00)00479-4","article-title":"Depletion of recipient CD8+ T cells does not alter the development of cardiac allograft vasculopathy.","volume":"20","author":"Szeto","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"R81-20260119","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1097\/00007890-200204150-00019","article-title":"Depletion of recipient CD4+ but not CD8+ T lymphocytes prevents the development of cardiac allograft vasculopathy.","volume":"73","author":"Szeto","year":"2002","journal-title":"Transplantation"},{"key":"R82-20260119","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/00007890-199504270-00014","article-title":"In vivo depletion of CD8+ T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection.","volume":"59","author":"Chan","year":"1995","journal-title":"Transplantation"},{"key":"R83-20260119","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/S0002-9440(10)63227-0","article-title":"Antigen location contributes to the pathological features of a transplanted heart graft.","volume":"164","author":"Chen","year":"2004","journal-title":"Am J Pathol"},{"key":"R84-20260119","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1111\/j.1600-6143.2006.01309.x","article-title":"CD154+ graft antigen-specific CD4+ T cells are sufficient for chronic rejection of minor antigen incompatible heart grafts.","volume":"6","author":"Huddleston","year":"2006","journal-title":"Am J Transplant"},{"key":"R85-20260119","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1053-2498(00)00507-6","article-title":"CD8+ lymphocytes participate in the development of chronic rejection.","volume":"20","author":"Fischbein","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"R86-20260119","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00007890-200104270-00023","article-title":"CD8+ lymphocytes augment chronic rejection in a MHC class II mismatched model.","volume":"71","author":"Fischbein","year":"2001","journal-title":"Transplantation"},{"key":"R87-20260119","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/0952-7915(91)90102-7","article-title":"Structural aspects of allorecognition.","volume":"3","author":"Lechler","year":"1991","journal-title":"Curr Opin Immunol"},{"key":"R88-20260119","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1084\/jem.175.1.305","article-title":"Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.","volume":"175","author":"Benichou","year":"1992","journal-title":"J Exp Med"},{"key":"R89-20260119","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1084\/jem.175.6.1521","article-title":"Rejection of skin allografts by indirect allorecognition of donor class I major histocompatibility complex peptides.","volume":"175","author":"Fangmann","year":"1992","journal-title":"J Exp Med"},{"key":"R90-20260119","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1084\/jem.175.6.1663","article-title":"T cell recognition of self-human histocompatibility leukocyte antigens HLA-DR peptides in context of syngeneic HLA-DR molecules.","volume":"175","author":"Liu","year":"1992","journal-title":"J Exp Med"},{"key":"R91-20260119","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1073\/pnas.90.8.3373","article-title":"The role of \u201cindirect\u201d recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice.","volume":"90","author":"Auchincloss","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R92-20260119","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0167-5699(93)90163-F","article-title":"Determinant spreading and the dynamics of the autoimmune T-cell repertoire.","volume":"14","author":"Lehmann","year":"1993","journal-title":"Immunol Today"},{"key":"R93-20260119","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1034\/j.1600-6143.2003.30105.x","article-title":"Further analysis of the T-cell subsets and pathways of murine cardiac allograft rejection.","volume":"3","author":"Yamada","year":"2003","journal-title":"Am J Transplant"},{"key":"R94-20260119","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.3389\/fimmu.2018.03038","article-title":"Germinal center alloantibody responses mediate progression of chronic allograft injury.","volume":"9","author":"Chhabra","year":"2018","journal-title":"Front Immunol"},{"key":"R95-20260119","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/00007890-199904270-00002","article-title":"Indirect recognition of donor HLA class I peptides in lung transplant recipients with bronchiolitis obliterans syndrome.","volume":"67","author":"SivaSai","year":"1999","journal-title":"Transplantation"},{"key":"R96-20260119","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1053-2498(00)00281-3","article-title":"Indirect allorecognition and alloantibody production precede obliterative airway disease development after tracheal transplantation in mice.","volume":"20","author":"Smith","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"R97-20260119","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1681\/ASN.V131252","article-title":"Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients.","volume":"13","author":"Najafian","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R98-20260119","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/00007890-199709270-00001","article-title":"Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction.","volume":"64","author":"Vella","year":"1997","journal-title":"Transplantation"},{"key":"R99-20260119","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.4049\/jimmunol.167.12.7199","article-title":"Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy.","volume":"167","author":"Baker","year":"2001","journal-title":"J Immunol"},{"key":"R100-20260119","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1073\/pnas.051584498","article-title":"Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy.","volume":"98","author":"Lee","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R101-20260119","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.4049\/jimmunol.161.3.1292","article-title":"Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts.","volume":"161","author":"Pettigrew","year":"1998","journal-title":"J Immunol"},{"key":"R102-20260119","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1600-6143.2004.00520.x","article-title":"Alloantibody production is regulated by CD4+ T cells\u2019 alloreactive pathway, rather than precursor frequency or Th1\/Th2 differentiation.","volume":"4","author":"Sauve","year":"2004","journal-title":"Am J Transplant"},{"key":"R103-20260119","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.183.2.699","article-title":"Two levels of help for B cell alloantibody production.","volume":"183","author":"Steele","year":"1996","journal-title":"J Exp Med"},{"key":"R104-20260119","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/00007890-199712150-00005","article-title":"Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis: lack of progression to sclerotic lesions in B cell-deficient mice.","volume":"64","author":"Russell","year":"1997","journal-title":"Transplantation"},{"key":"R105-20260119","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.trim.2008.03.003","article-title":"CD8(+) T cells mediate aortic allograft vasculopathy under conditions of calcineurin immunosuppression: role of IFN-gamma and CTL mediators.","volume":"19","author":"Nejat","year":"2008","journal-title":"Transpl Immunol"},{"key":"R106-20260119","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1053-2498(02)00465-5","article-title":"CD8(+) T cells induce graft vascular occlusion in a CD40 knockout donor\/recipient combination.","volume":"22","author":"Raisky","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"R107-20260119","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI70084","article-title":"B cells mediate chronic allograft rejection independently of antibody production.","volume":"124","author":"Zeng","year":"2014","journal-title":"J Clin Invest"},{"key":"R108-20260119","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1600-6143.2006.01599.x","article-title":"Chronic cardiac transplant arteriopathy in mice: relationship of alloantibody, C4d deposition and neointimal fibrosis.","volume":"7","author":"Uehara","year":"2007","journal-title":"Am J Transplant"},{"key":"R109-20260119","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1600-6143.2011.03836.x","article-title":"A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody.","volume":"12","author":"Hirohashi","year":"2012","journal-title":"Am J Transplant"},{"key":"R110-20260119","doi-asserted-by":"crossref","first-page":"5135","DOI":"10.4049\/jimmunol.152.10.5135","article-title":"Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity.","volume":"152","author":"Russell","year":"1994","journal-title":"J Immunol"},{"key":"R111-20260119","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1111\/j.1600-6143.2009.02804.x","article-title":"HLA class I antibodies provoke graft arteriosclerosis in human arteries transplanted into SCID\/beige mice.","volume":"9","author":"Galvani","year":"2009","journal-title":"Am J Transplant"},{"key":"R112-20260119","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1161\/CIRCULATIONAHA.113.002972","article-title":"Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-\u03baB signaling in endothelial cells.","volume":"128","author":"Jane-Wit","year":"2013","journal-title":"Circulation"},{"key":"R113-20260119","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.4049\/jimmunol.1003253","article-title":"Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates.","volume":"187","author":"Nadazdin","year":"2011","journal-title":"J Immunol"},{"key":"R114-20260119","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/TP.0b013e3182122f82","article-title":"Coronary artery disease from isolated non-H2-determined incompatibilities in transplanted mouse hearts.","volume":"91","author":"Russell","year":"2011","journal-title":"Transplantation"},{"key":"R115-20260119","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.4049\/jimmunol.167.10.5731","article-title":"Tolerance, mixed chimerism, and chronic transplant arteriopathy.","volume":"167","author":"Russell","year":"2001","journal-title":"J Immunol"},{"key":"R116-20260119","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.transproceed.2006.10.147","article-title":"T-cell depletion eliminates the development of cardiac allograft vasculopathy in mice rendered tolerant by the induction of mixed chimerism.","volume":"38","author":"Uehara","year":"2006","journal-title":"Transplant Proc"},{"key":"R117-20260119","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.4049\/jimmunol.162.11.6836","article-title":"De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process.","volume":"162","author":"Fedoseyeva","year":"1999","journal-title":"J Immunol"},{"key":"R118-20260119","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1016\/S0041-1345(01)02617-3","article-title":"Detection of cardiac myosin-specific autoimmunity in a model of chronic heart allograft rejection.","volume":"33","author":"Rolls","year":"2001","journal-title":"Transplant Proc"},{"key":"R119-20260119","first-page":"227","article-title":"The role of autoimmunity in the pathogenesis of lung allograft rejection.","volume":"51","author":"Wilkes","year":"2003","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"R120-20260119","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1744-313X.2012.01112.x","article-title":"An important role for autoimmunity in the immunopathogenesis of chronic allograft rejection.","volume":"39","author":"Tiriveedhi","year":"2012","journal-title":"Int J Immunogenet"},{"key":"R121-20260119","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0167-5699(91)90118-D","article-title":"Autoimmune myocarditis: concepts and questions.","volume":"12","author":"Rose","year":"1991","journal-title":"Immunol Today"},{"key":"R122-20260119","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.4049\/jimmunol.147.7.2141","article-title":"Myosin-induced acute myocarditis is a T cell-mediated disease.","volume":"147","author":"Smith","year":"1991","journal-title":"J Immunol"},{"key":"R123-20260119","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1111\/j.1600-6143.2005.01022.x","article-title":"Humoral immunity to vimentin is associated with cardiac allograft injury in nonhuman primates.","volume":"5","author":"Azimzadeh","year":"2005","journal-title":"Am J Transplant"},{"key":"R124-20260119","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/00007890-200104150-00011","article-title":"Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation.","volume":"71","author":"Jurcevic","year":"2001","journal-title":"Transplantation"},{"key":"R125-20260119","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/TP.0b013e3181dfa694","article-title":"Autoimmunity to vimentin potentiates graft vasculopathy in murine cardiac allografts.","volume":"90","author":"Mahesh","year":"2010","journal-title":"Transplantation"},{"key":"R126-20260119","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.2741\/2393","article-title":"Induction of autoimmunity after allotransplantation.","volume":"12","author":"Benichou","year":"2007","journal-title":"Front Biosci"},{"key":"R127-20260119","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1365-3083.2002.01053.x","article-title":"NK cells, MHC class I molecules and the missing self.","volume":"55","author":"Karre","year":"2002","journal-title":"Scand J Immunol"},{"key":"R128-20260119","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In search of the \u2018missing self\u2019: MHC molecules and NK cell recognition.","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol Today"},{"key":"R129-20260119","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.4049\/jimmunol.175.5.3424","article-title":"NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts.","volume":"175","author":"Uehara","year":"2005","journal-title":"J Immunol"},{"key":"R130-20260119","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.it.2018.10.003","article-title":"Bystander T cells: a balancing act of friends and foes.","volume":"39","author":"Whiteside","year":"2018","journal-title":"Trends Immunol"},{"key":"R131-20260119","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0198-8859(00)00209-3","article-title":"Induction of T-cell response to cryptic MHC determinants during allograft rejection.","volume":"61","author":"Boisgerault","year":"2000","journal-title":"Hum Immunol"},{"key":"R132-20260119","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/CIRCRESAHA.107.151068","article-title":"Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation.","volume":"101","author":"Wang","year":"2007","journal-title":"Circ Res"},{"key":"R133-20260119","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35003221","article-title":"Interferon-gamma elicits arteriosclerosis in the absence of leukocytes.","volume":"403","author":"Tellides","year":"2000","journal-title":"Nature"},{"key":"R134-20260119","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1096\/fj.03-0840fje","article-title":"Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries.","volume":"18","author":"Wang","year":"2004","journal-title":"FASEB J"},{"key":"R135-20260119","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1111\/j.1600-6143.2007.01997.x","article-title":"Macrophage depletion suppresses cardiac allograft vasculopathy in mice.","volume":"7","author":"Kitchens","year":"2007","journal-title":"Am J Transplant"},{"key":"R136-20260119","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.aax4040","article-title":"PIRs mediate innate myeloid cell memory to nonself MHC molecules.","volume":"368","author":"Dai","year":"2020","journal-title":"Science"},{"key":"R137-20260119","first-page":"791","article-title":"Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells.","volume":"138","author":"Salomon","year":"1991","journal-title":"Am J Pathol"},{"key":"R138-20260119","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/CIRCULATIONAHA.119.044924","article-title":"Identification and characterization of trajectories of cardiac allograft vasculopathy after heart transplantation: a population-based study.","volume":"141","author":"Loupy","year":"2020","journal-title":"Circulation"},{"key":"R139-20260119","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-6143.2010.03383.x","article-title":"De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival.","volume":"11","author":"Smith","year":"2011","journal-title":"Am J Transplant"},{"key":"R140-20260119","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.healun.2017.09.011","article-title":"Prevalence of polyreactive innate clones among graft--infiltrating B cells in human cardiac allograft vasculopathy.","volume":"37","author":"Chatterjee","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"R141-20260119","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/TP.0b013e3181d3f271","article-title":"B cells and plasma cells in coronaries of chronically rejected cardiac transplants.","volume":"89","author":"Wehner","year":"2010","journal-title":"Transplantation"},{"key":"R142-20260119","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.4049\/jimmunol.1004195","article-title":"Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients.","volume":"187","author":"Kalache","year":"2011","journal-title":"J Immunol"},{"key":"R143-20260119","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.healun.2010.05.025","article-title":"Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy.","volume":"29","author":"Nath","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"R144-20260119","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fimmu.2017.00170","article-title":"Role of memory T cells in allograft rejection and tolerance.","volume":"8","author":"Benichou","year":"2017","journal-title":"Front Immunol"},{"key":"R145-20260119","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1182\/blood-2009-07-234906","article-title":"Allo-HLA reactivity of virus-specific memory T cells is common.","volume":"115","author":"Amir","year":"2010","journal-title":"Blood"},{"key":"R146-20260119","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/eji.1830270720","article-title":"Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.","volume":"27","author":"Burrows","year":"1997","journal-title":"Eur J Immunol"},{"key":"R147-20260119","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/ajt.13618","article-title":"Virus-specific CD8 T-cells cross-reactive to donor-alloantigen are transiently present in the circulation of kidney transplant recipients infected with CMV and\/or EBV.","volume":"16","author":"Heutinck","year":"2016","journal-title":"Am J Transplant"},{"key":"R148-20260119","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/TP.0b013e3181ff4ff3","article-title":"Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients.","volume":"90","author":"Mifsud","year":"2010","journal-title":"Transplantation"},{"key":"R149-20260119","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1001\/jama.1989.03420240075030","article-title":"Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis.","volume":"261","author":"Grattan","year":"1989","journal-title":"JAMA"},{"key":"R150-20260119","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0735-1097(96)00201-X","article-title":"Early development of accelerated graft coronary artery disease: risk factors and course.","volume":"28","author":"Gao","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"R151-20260119","first-page":"707","article-title":"Role of cytomegalovirus infection in the development of coronary artery disease in the transplanted heart.","volume":"9","author":"Loebe","year":"1990","journal-title":"J Heart Transplant"},{"key":"R152-20260119","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S1053-2498(03)00222-5","article-title":"Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin.","volume":"23","author":"Atkinson","year":"2004","journal-title":"J Heart Lung Transplant"},{"key":"R153-20260119","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1161\/CIRCULATIONAHA.105.576017","article-title":"Extracardiac progenitor cells repopulate most major cell types in the transplanted human heart.","volume":"112","author":"Minami","year":"2005","journal-title":"Circulation"},{"key":"R154-20260119","first-page":"65","article-title":"Antigen presentation by B lymphocytes: a critical step in T-B collaboration.","volume":"130","author":"Lanzavecchia","year":"1986","journal-title":"Curr Top Microbiol Immunol"},{"key":"R155-20260119","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1161\/01.CIR.101.20.2405","article-title":"Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection.","volume":"101","author":"Hornick","year":"2000","journal-title":"Circulation"},{"key":"R156-20260119","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1046\/j.1523-1755.1999.00751.x","article-title":"Why do we reject a graft? Role of indirect allorecognition in graft rejection.","volume":"56","author":"Sayegh","year":"1999","journal-title":"Kidney Int"},{"key":"R157-20260119","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1111\/ajt.16333","article-title":"T cell repertoire analysis suggests a prominent bystander response in human cardiac allograft vasculopathy.","volume":"21","author":"Habal","year":"2021","journal-title":"Am J Transplant"},{"key":"R158-20260119","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.1038\/s41467-019-13113-5","article-title":"Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants.","volume":"10","author":"Koenig","year":"2019","journal-title":"Nat Commun"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:01:06Z","timestamp":1768834866000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":158,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005453","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]}}}